Hoʻohālikelike Nānā: Ka Molecular a me nā Hana Maʻemaʻe o ka Hana Pūnaewele (2015))

ʻO Biomed Res Int. 2015; 2015: 378675. Epub 2015 Mar 24.

Zhu Y1, Zhang H1, Tian M1.

Volume 2015 (2015), NĀ Palapala X XUMUM, Nā 378675

http://dx.doi.org/10.1155/2015/378675

Yunqi Zhu, 1,2,3,4 Hong Zhang, 1,2,3,4 a me Mei Tian1,2,3,4

1Department o Nuclear Medicine, Ka lua o ka haukapila o Zhejiang University School Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009, Kina
2Zhejiang Kula Pūnaewele PET a Hangzhou 310009, Kina
3Institute of Medicine Nuclear and Molecular Imaging, Ke Kulanuiʻo Zhejiang, Hangzhou 310009, Kina
ʻO ka 4Key Keena Hana No nā Molecular Imaging o Zhejiang Province, Hangzhou 310009, Kina

Loaʻa ʻo 18 Iulai 2014; ʻNlelo ʻia ʻo 8 ʻOkakopa 2014

Lunahooponopono ʻOihana: Ali Cahid Civelek

Kuleana kope © 2015 Yunqi Zhu et al. He ʻatikala ala wehe ʻia kēia i hoʻoili ʻia ma lalo o ka ʻAha Hoʻomaopopo o ka ʻAha Kūkākūkā ʻAha Mīkini, e ʻae ana i ka hoʻohana ʻole ʻia, ka hoʻoili ʻana, a me ka hoʻouluulu ʻana i nā ʻano hana, kahi i ʻike pono ʻia ai ka hana kumu.

Hōʻuluʻulu Manaʻo

ʻO ka hoʻohana ʻana ʻo Maladaptive i nā hopena pūnaewele ma ka hoʻohui ʻana i ka Pūnaewele (IA), i pili pū me nā hopena maikaʻi ʻole. Ua hoʻonui ʻia nā hana molecular me ka hoʻohana ʻana i ka hana no ka nānā ʻana i nā loli neurobiological a me nā correlates neurochemical o IA. Hoʻomaopopo kēia loiloi i nā ʻikepili a me ka hana hoʻomālamalama hana e pili ana i ka hana neurobiological o IA, e nānā ana i ka magneton resonance imaging (MRI) a me nā hana o ka hoʻoulu ʻana i ka nukle e komo pū ana i ka tomography positron. Hōʻike nā haʻawina MRI e pili ana nā loli o ka hana ma mua o cortex me ka mau hewa i hana ʻia ma nā kumuhana pili i ka pūnaewele. Hōʻike nā hōʻike Imaging nuklea e pili ana ʻo IA i ka hana ʻana o nā ʻōnaehana dopaminergic ute. ʻO ka hoʻoponopono dopamine Abnormal o ka cortex prefrontal (PFC) i hiki ke hoʻomohala i ka waiwai hoʻoikaika hoʻoikaika a me ka hana ʻole i ke kāohi ʻia ma luna o ka Pūnaewele pili i nā kumumanaʻo. Pono nā noiʻi hou aʻe e hoʻoholo i nā loli kūikawā i ka lolo o ka pūhui addictive pūnaewele, a me ko lākou mau hopena no ka hana a me ka cognition.

1. Introduction

ʻO ka hoʻohui i nā mea a i ʻole nā ​​hana e hiki ke hoʻopilikia nui i ka olakino o nā kānaka a i kekahi manawa ke alakaʻi ʻia i nā pilikia lehulehu i [1-3]. No ka laʻana, hiki ʻole i ka hoʻohana maladaptive i ka Pūnaewele ke hiki i ka hoʻomohala ʻana o kahi mea pili i ka hanana, e alakaʻi ana i ka hōʻeha kino ʻana a i ʻole pilikia [4]. ʻO ka mea i hala koke nei, ua hoʻonui nui ka noiʻi e pili ana i ka pono o ka Pūnaewele (IA), ʻoi aku ka pilikia o ka pāʻani pūnaewele (IGD) ma ka nui a ma ka maikaʻi [5, 6]. Ua ho'ākāka pinepine ʻia ʻo IA me ka hiki ʻole o nā poʻe i ka mālama i kā lākou hoʻohana ʻana i ka Pūnaewele, e pili ana i nā hōʻailona psychological, social, a / a i ʻole nā ​​hana hana [7]. Hoʻopili ʻo IA me nā hopena maikaʻi ʻole, e like me ka kaumaha ʻana i nā hana maoli, ka nānā ʻole ʻana o ka maka, ka huhū a me ka huhū, ka hopohopo, disfunctional coping.

ʻOiai ua kālaiʻo IA i ka nānā nui ʻana mai ka honua ʻepekema, ʻaʻohe o kēia mau laʻamau no ka maʻi diagnostic. Ua hōʻike ʻia kekahi mau laikini diagnostic e hoʻopaʻa i ka IA. ʻO ka hoʻohana pinepine ʻana no ka noi diagnostic ʻo Young's Diagnostic Questionnaire [8-10]. Hoʻokumu ʻia ma ka Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), ʻo Iā Mamua ua kūkulu i kahi nīnau noiʻewalu kāwalu helu i loiloi ʻia IA [8]. I ka hoʻohana ʻana i kēia mau koi, ua helu ʻia nā mea hoʻohana me ʻelima a i ʻole o nā ʻewalu mau i hōʻike ʻia i loko o nā mahina ʻo 6 i hala. Ua hana hou ʻo Young i kahi nīnau no 20-item, i kapa ʻia ʻo ka Pūnaewele Hoʻomau Hōʻike Pūnaewele [10]. Ma ka nīnau nīnau 20-item, ua hoʻokumu ʻia kēlā me kēlā me kēia ma kahi kiko he 5-point Likert e loiloi ana i ka loaʻa ʻana o nā pilikia ma o ka hoʻohana pūnaewele. Hōʻike i nā helu ma 50 i nā pilikia e pili ana i ka pūnaewele a i ʻole ka maʻamau a me nā helu ma luna o 80 e hōʻike i nā pilikia nui e pili ana i ka ola [10]. Ua hoʻāʻo ʻia ka Pūnaewele Hoʻomau Pūnaewele he mea kūpono a pono e hiki ke hoʻohana ʻia ma ka helu ʻana i ka IA [11]. ʻO nā mea hoʻohana ʻē aʻe a me nā mea nānā screening a me ka mea i hana ʻia e loiloi ai i ka IA [12-16].

ʻO kahi mea nui he subtype koʻikoʻi a IA, ua loaʻa ka IGD a me ka nānā hou aku mai ka honua holoʻokoʻa. Ua hoʻokomo ʻia ʻo IGD i ka manawa i loaʻa iā DSM-V, me ka pahuhopu e hoʻoikaika ai i nā haʻawina hou [4]. Ka wehewehe ʻana ka DSM-V i ka IGD ma "ka hoʻohana mau ʻana a ka ʻoihana pūnaewele e hana i nā pāʻani, pinepine me nā mea pāʻani ʻē aʻe, e alakaʻi ana i ka hōʻeha poʻokela paha a hopohopo paha e hōʻike ʻia ana e ka ʻelima a ʻoi aku paha (mau manaʻa) i kahi mahina 12" 5].

I nā makahiki i hala iho nei, ua māhuahua ka lōʻihi o nā mehele a me nā hana lawelawe imaging no ka hoʻopaʻa ʻana i ka hana neurobiological ma lalo o IA. ʻO ka imaging molecular he mākā wikiwiki e hoʻomohala ana i ka hāʻawi ʻana i nā ʻike molekone pili i ka maʻi ma o nā noiʻi diagnostic imaging [17]. Hiki ke wehewehe nui ʻia ka huaʻōlelo ʻo ka molaging molaging e like me ka vivo characterization a me ke ana ʻana o nā kaʻina biologic ma ka pūpū o ka cellular a me nā molekula [18]. I mea e pale ai a mālama i ka IA, he mea nui ia e ʻike i kahi hoʻomohala ʻana i kāna mau hana lalo. ʻO ka holomua ʻana o ka ʻenehana ua hoʻohana ʻia i ka hoʻohana nui ʻana o ka hana hoʻonaninua ʻenehana a me nā hana hana, no ka laʻana, ka magnetic resonance imaging (MRI), positron emission tomography (PET), a me nā kiʻi foton i hoʻohālikelike i ka tomography (SPECT), e kōkua ai i ka nānā ʻana i nā ʻano ʻokoʻa. nā maʻi maʻi me ka hoʻopaʻa ʻia ʻana o IA. Maanei mākou e hōʻike ai i nā haʻawina hoʻonaninani a me nā hana loea hou i hāʻawi ʻia i nā ʻike nui i nā hana neurobiological o IA, e noʻonoʻo pono ana i nā ala ʻo MRI a me PET.

2. Nā ʻĀina ʻo MRI

ʻO ka MRI kahi hana mode imagingous loa e hoʻohana ana i ka mana a me ka ikehu radiofrequency e ʻike i ke ʻano o loko a me ka morphology kiko o ke kino [19]. ʻO ka pono mua o MRI ma o ka modaging imaging modality ʻo ia kona kiʻekiʻe spatial hoʻonā (micrometer), e ʻae ana i ka ʻokoʻa a me ka ʻike anatomical e ʻohi ʻia i ka manawa like. ʻO Functional MRI (fMRI) kahi hana noninvasive hiki ke hoʻohana i ka nānā ʻana i nā hana metabolic i nā loli o ka lolo [20]. Ua hōʻoia ia aia ka piʻi ʻana o ka hana neuronal ma loko o kahi ʻāpana o ka lolo e alakaʻi ai i ka piʻi nui ʻana o ka nui o ka kahe koko e hele ana i loko o kēlā wahi kikoʻī [21]. Mai ka deoxygenated hemoglobin e paramagnetic, a me ka hemoglobin oxygenated he diamagnetic, ua hoʻoneʻeneʻe ʻia ka nui-oxygen-level-dependant (BOLD) e nānā i ka lolo o ka lolo ma ka hana ʻana ma nā wahi like ʻole a me nā koi ʻana.

2.1. Nā Hoʻololi Kūlohelohe

Ke hoʻohana nei i MRI, ua hōʻike kekahi mau noiʻi ua pili nā hoʻololi o ka lolo i ka IA. Ke hoʻohana nei i ka hōʻike ʻana ʻo Stroop color-word test [22], kahi i hoʻohana nui ʻia no ka loiloi ʻana i ka pale inhibitory, ua hōʻike ʻia kahi noiʻi e hōʻike ana nā ʻōpiopio me ka IGD i nā hemahema cognitive control kakayahan [23]. Hōʻike nā hopena o nā hōʻike i ka pili ʻana o ka lolo i ka hana hoʻokele, no ka laʻana, ka ʻulaʻi orbitofrontal cortex hema (OFC), insula cortex, a me ka cortex entorhinal, hōʻike i ka hoʻohaʻahaʻa cortical mānoina ma nā kumuhana IGD i hoʻohālikelike ʻia me nā mana hoʻomohala (Figure 1). Eia kekahi, hōʻike pū nā mea kākau ua hōʻemi ʻia ka mānoanoa cortical o ka hema hema o ka hema o OFC me ka hiki ʻana o ka mana cognitive control i ka ʻōpio ʻo Hawaiʻi. E kūlike me kēia, ua hōʻike hou ʻia kekahi noiʻi i ka emi o ka mānoanoa o ka OFC o ka ʻenemi i hoʻohui ʻia i ka pūnaewele [24]. Hāʻawi ʻia i ka manaʻo e hoʻokomo ʻia ka OFC i ke ala o nā lāʻau lapaʻau a me nā mea pili i ke ʻano [25, 26], ua hōʻike nā mea kākau e hōʻike ana ʻo IA i nā ʻano like ne like me ka hana neʻe. Ma waho o ka emi o ka mānoanoa cortical, ua ʻike ʻia ka mānoanoa cortical i nānā ʻia ma ka cortex hema hema, precuneus, cortex mua waena, a me nā cortices temporal waena a me ka waena [23] (Figure 1). Hoʻopili ʻia ka precuneus me ka noʻonoʻo noʻonoʻo, ka nānā ʻana, a me ka hoʻihoʻi mai [27]. ʻO ka cortex temporal haʻahaʻa a me ke cortex mua waena i hōʻike ʻia e pili i ke kiʻi ʻana i ke ʻano o ka cues coting [28, 29]. No laila, eia nā hualoaʻa e pili ana i ka nui o nā wahi laulā cortical i IGD e pili ana me ka makemake i nā cues gaming.

Hōʻike 1: ʻO nā hoʻokaʻawale poloka hāpili i nā wā'ōpiopio me ka IGD i hoʻohālikelike ʻia me nā mana olakino. I ʻike ʻia ka mānoanoa cortical i mau wahi i loko o nā ʻōpio me ka IGD i hoʻohālikelike ʻia i nā mana olakino, ʻo ia hoʻi, ʻo ka cortex hema hema, precuneus, cortex mua waena a me nā pōkole temporal a waena. ʻO ka hoʻoneʻe cortical kaila ma ka ʻaoʻao hema o ka OFC, insula cortex, a me ka lingual gyrus, me ka ʻaoʻao postcentral gyrus, cortex entorhinal, a me ka puʻupuʻu kahunaetal cortex i ʻike ʻia i nā wā ʻōpio me IGD [23].

ʻO ka morphometry e pili ana i Voxel kahi hana unbiased no ka hōʻike ʻana i ka nui cerebral regional a me ka hoʻoliʻi kūwili o nā kiko i nā kiʻi hoʻohālikelike magnetic [30, 31]. Ua loaʻa nui nā morphometry e pili ana i ka Voxel i ka ʻike ʻana i ka nui o ka maʻi maʻamau i loko o nā ʻano like ʻole o ka maʻi neʻe. Ua hōʻike ʻia nā haʻawina morphometry a Voxel e pili ana i ka wā ʻōpio ʻo IGD ka haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa ma ka hema cortex anterior Cortex (ACC) hema, hema hema cortex (PCC), hema insula, a waiho iā lingual gyrus [32]. Ke hoʻohana nei i ka like me kēia, ua hōʻemi ʻia ka nui o nā kumu hina hina i loko o ka bilateral dorsolateral PFC, wahi ʻokoʻa a me ka ʻUwili, OFC, cerebellum, a waiho i ka Aostostost rostral ma kahi hui o nā ʻōpio o nā ʻenekena lula [33]. Hoʻohui ʻia, hōʻike ʻia kahi haʻawina hoʻākāka mua o Voxel-morphometry i ka hoʻohuihui ʻana i ka hina haʻahaʻa ma OFC kūpono, bilateral insula, a me nā wahi kīnā pono a IGD [34]. ʻAʻole mau nā hopena o ke aniani hina ma waena o kēia mau noiʻi, ʻo ia paha ma muli o nā ʻano loiloi ʻikepili like ʻole. Ua hoʻokomo ʻia ka PFC i ka hoʻolālā ʻana i ka hanana cognitive paʻakikī, hōʻike pilikino, a me ka hoʻoholo 'ana, ka mea o ka dorsolateral PFC, ACC, a me OFC [35]. Ua lawe ʻia nā haʻawina hoʻonaʻauao lehulehu i ka hana o ka PFC i ka hoʻohui (36]. I kēia manawa ʻike maʻamau ia e hana nei nā OFC i kahi hana nui ma ka hoʻomohala a me ka hoʻoholo i [26, 37]. Ua hōʻike ʻia nā noiʻi imaging functionally hopohopo ua pili nā dorsolateral PFC a me rostral ACC i pili i ka mālama cognitive [38, 39]. ʻO ka nui o nā hina hina i loko o ka PFC e pili ana me ka mālama ʻole ʻole ʻia ma ka addict pūnaewele, e wehewehe pono i nā hōʻailona kumu o IA. Ua manaʻo ʻia ka insula e hana i kahi kūlana koʻikoʻi i ka mea i hoʻohui ʻia [40]. Hoike i kekahi mau haʻawina Imaging hāmeʻa pono e hōʻike i ka insula e pono no ka uakiʻi pono e lawe i nā lāʻau lapaʻau, a hana maʻamau kēia hana i waena o nā mea hana kolohe [41, 42]. No laila, ua kūpono kēia mau hualoa me ka ʻike mua a hōʻoia i ka mana pono o ka PFC a me ka insula no ka hoʻohui.

'Usionlelo' ana o ka diffusion tensor imaging (DTI) kahi ala i hiki ai ke kiʻekiu i nā ʻili kelepona keʻokeʻo noninvasively. Loaʻa ka ʻōhumu o nā molekala wai i ka wikiwiki o ke kaila helehelena ma mua o nā ʻōmole iā lākou. ʻO ka ʻokoʻa ma waena o kēia mau ʻōpiehana ʻelua ke kumu o DTI [43, 44]. Hāʻawi ʻo DTI i kahi hana no ka loaʻa, ka nānā ʻana, a me ka helu ʻana o nā waiwai o ka wehe ʻana i nā mea keʻokeʻo. ʻO ka hoʻohuiʻana i nā mea hina hina, ua ʻōlelo pū ʻia nā mea keʻokeʻo keʻokeʻo ma IGD. Ke hoʻohana nei i ka DTI, kahi loiloi i nānā ʻia i ke kūloko hihia keʻokeʻo ma nā mea pono me ka IGD [45]. Ua hōʻike ʻia ka anisotropy kiʻekiʻe ʻoi fractional i loko o ka thalamus a waiho iā PCC i ka IGD pili i nā mana olakino. Eia kekahi, ʻoi aku ka nui o ka anisotropy fractional i ka thalamus i pili me ka nui o ka IGD. Ua hōʻike ʻia hoʻi nā mea lahilahi ke keʻokeʻo ma nā ʻāina ʻē aʻe o nā haʻawina ʻē aʻe. No ka mea laahi, ua hōʻike ʻia a hoʻemi ʻia ka anisotropy fractional i hoʻohui ʻia i loko o kahi noiʻi, me ka anisotropy fractional i hoʻonui ʻia i ka pihi hema o ka capsule o loko a hōʻemi iho i ka anisotropy fractional ma ka ʻaoʻao parahippocampal gyrus [33]. Ma kekahi noiʻi, ua hōʻike nui ʻia ka anisotropy fractional haʻahaʻa ma ka ʻaoʻao o ka mea i hoʻopili ʻia o ka Pūnaewele, me ka PFC a me ACC [46]. Eia naʻe, ʻaʻohe mau wahi o ka anisotropy fractional kiʻekiʻe. Ua hōʻike ʻia nā hopena like ʻole ma kekahi pūʻulu o nā wā'ōpiopio me IGD [34]. Hōʻike kēia mau mea hōʻike i ka maʻi IA i hōʻike i nā mea maʻamau o ke keʻokeʻo e pili ana, e pili ana me kekahi mau hana hoʻokaumaha. Pono e hoʻomaopopo ʻia ka hoʻololi ʻia ʻana o nā anisotropy fractional i loko o nā wahi i ka lolo, a ʻo ke ʻano o ke ʻano i loko o kēia mau noiʻi e noiʻi hou.

2.2. Nā Kūpono Kūʻai

Ke hoʻohana ʻana i ka arterial spin-labeling perfusion fMRI, Feng et al. ua noi ʻia nā hopena o IGD ma ka hoʻomaha ʻana i ke kahe koko cerebral i loko o nā ʻōpio [47]. Hoʻohālikelike ʻia me nā kumumana hoʻomalu, nā ʻōpio me ka IGD i hōʻike nui loa i ke kahe koko cerebral nui i loko o ka limu ʻula hema hema / fusiform gyrus, hema parahippocampal gyrus / amygdala, mau ke alo pono mua medial / ACC, hema insula, insula ʻākau, ʻākau waena temporal gyrus, ʻākau gyrus precentral, left motor motor supplementation, left cingulate gyrus, and right inferior parietal lobe. Ua hoʻokomo ʻia ka hapa nui o kēia mau wahi i kahi hiʻohiʻona i hāʻawi ʻia e Volkow et al. ma loko o laila ka haki i ka haki ʻana no ke kaohi ʻana o ka ʻike a me ka hoʻohui ʻana ma waena o nā ʻekekī āpau a me nā hana [48]. Ma waena o kēia mau ʻaoʻao o ka lolo, ʻo ka amygdala a me nā hippocampus kahi ʻāpana o ka lepa i komo i ka aʻo ʻana a me ka hoʻomanaʻo e pili ana i ka moʻolelo e pili ana i nā kīʻaha pili lāʻau [49]. ʻO nā insula a me ka PFC, ua ʻike ʻia he hana koʻikoʻi nui i ka addiction [36, 40]. Ua loaʻa i ke kahe koko cerebral i loaʻa i ka gyrus waena waena hema, hema gyrus waena waena, a me nā kahe cingulate kanikani i ka wā'ōpiopio IGD. Hōʻike nā hopena i ko IGD e hoʻololi i ke kahe koko o ka cerebral ma ka lolo o ka ʻōpio. Eia nō naʻe, maopopo ʻole inā he hoʻohuli ʻia nei nā kaila koko o ka cerebral e pili ana i nā maʻi neʻokeʻo a me nā loli lua e uku ʻia no kēlā mau pōʻino.

Ua nānā ʻia nā hana hoʻopili pili pono i nā poʻe me IA. Ua hōʻike kahi haʻawina hou loa i hōʻike ʻia nā kumuhana me ka IGD i ka hoʻonui ʻia o ka hana hoʻopili paʻa ʻana i ka pebileli posterior biletralum a me ka gyrus waena waena i hoʻohālikelike ʻia me ka hui pū [50]. ʻO ka lua wai i hoʻowalewale i ka hoʻoweliweli parietal o ka gyrus temporalal i hōʻike i ka hoʻohaʻahaʻa. Ua hōʻike ʻia kekahi noiʻi ʻē aʻe i ka wā ʻōpio me IA i hōʻemi ʻia ka pili ʻana i ka hana me ka cortico-subcortical circuits, a ʻo ka bilateral putamen ka mea i hoʻopili nui ʻia ma ka ʻekekaumaha kaʻina subortical [51]. Hōʻike kēia mau hopena i ka pili ʻana o IA i kahi pālahalaha nui a me ka nui o ka hoʻohuihui ʻana i hana ʻia i kahi ʻoha i māhele ʻia.

Ua hōʻike ʻia e pili pū ka impulsivity me IA [52]. ʻO ka hiki ke kāohi i ka pane o ka mīkini i hoʻolālā ʻia e hoʻohana pinepine ʻia me ka hoʻohana ʻana i ka hōʻailona-i ʻole a i ʻole / hele-no paradigms [53]. Ua hōʻike ʻia kahi noiʻi hou ʻana i ka pane ʻana a me ka hoʻokaʻawale hewa ʻana i nā kumuhana me IGD [54]. Ua hana nā kumu āpau i kahi hana i pili i ka hanana / no-hele ma lalo o fMRI a ua hoʻopau i nā nīnau nīnau pili i ka IA a me ka impulsivity. Loaʻa i ka pūʻulu IGD ka helu kiʻekiʻe no ka impulsivity a hōʻike i ke kiʻekiʻe o ka hoʻoweliweli ʻana i ka wā e hoʻōla ana i ka pane ʻana o ka pane ma ka hema o OFC a me ka bilateral caudate nucleus ma mua o nā kaohi. Ua hui pū ka OFC me ka pane ʻana o [tugon ma 37, 55]. No laila, kākoʻo kēia mau hopena i ka ʻoiaʻiʻo i pili i ka pūnaewele fronto-striatal pili i ka pale ʻana i ka pane. Ua nānā ʻia kahi like like me nā neural correlations o ka pale ʻana i nā kāne me IA me ka hoʻohana ʻana i kahi hanana i pili ʻia puhaluhi like fMRI Stroop [56]. Ua hōʻike ka pūʻulu IA nui loa i ka hana "Stroop effect"-pili pili ma ka ACC a me PCC hoʻohālikelike ʻia me nā koina olakino. Ua hōʻike ʻia ʻo ACC e pili i ka hoʻopiʻi kaua a me ka mana hoʻomohala [57, 58]. ʻO ka nui o ka hana ACC ma mua o ka hana Stroop color-word task e noʻonoʻo i ka emi ʻana o "ka noʻonoʻo cognitive" i ka pūʻulu IA. ʻO PCC kahi kikowaena o ka paʻamau mode paʻahana a ua hoʻokomo ʻia i nā kaʻina attentional [59]. ʻO ka hoʻonui nui aʻe ma ka PCC hiki ke hōʻike i ka piha piha ʻana o ka ʻike mode like ka hopena i ka hiki ʻole ʻana i nā hana pili i ʻike ʻia i loko o ka pūʻulu IA. Hōʻike kēia mau hopena i nā mea hōʻike me IA i hōʻike i ka emi ʻana o ka hana o ka hoʻomaʻamaʻa pane-inhibition.

ʻO ke ʻano homogeneity o ka ʻāina ka nui o ka hoʻohana ʻana i nā haʻawina fMRI e ana i ka hana kiko o kekahi voxel i hāʻawi ʻia me kona mau hoalauna kokoke, a hiki ke hoʻohana ʻia e loiloi i nā hana ʻoluʻolu o ka lula e pili ana i ka hypothesis e pili ana i nā leo kīkē e pili kokoke ana i nā hana pilikino. 60]. Hōʻike nā kumuhana IGD i ka nui e hoʻonui i ka home homogeneity i loko o ka limulu parietal inferior, waiho i ka posterior cerebellum, a waiho i kahi gyrus waena waena a hoʻemi i ka homogeneity kūloko ma ka wā kino, occipital, a me nā ʻāpana ʻula o ka parietal i hoʻohālikelike ʻia me nā mana olakino [61]. Hōʻike nā hopena i ka pāʻani lōʻihi o ka pāʻani pūnaewele ma ka lolo ʻana i ka naʻau o ka naʻau i ka hoʻoponopono ʻana i ka sensory-motor e pili ana i nā wahi o ka lolo a me ka hoʻohaʻahaʻa ʻana i ka mana o nā lolo o ka noʻonoʻo a me ka auditory.

Nui nā noiʻi i noiʻi i nā wahi o ka lolo e pili ana i ka pāʻani cue-induced gaming urges [62-65]. Hāʻawi ʻia nā mea i hōʻike i nā kiʻi pāʻani ma ke kiʻi ʻana i ka fMRI. Hōʻike kēia mau noiʻi i ka hana hoʻomohala i nā wahi noʻonoʻo i hoʻolilo ʻia (e like me, dorsolateral PFC, inetior parietal lobe, ACC, parahippocampal gyrus, OFC, a me PCC) i ka hui hoʻohui me ka hui pū ʻana. Ua hōʻuluʻulu maikaʻi nā ʻōnaehana hoʻōla i hoʻōla ʻia me nā pīkau ʻana o ka pāʻani pili ponoʻī. Ua hoʻokaʻawale ʻia nā mea maʻamau i loko o kēia mau ʻāina i ka hoʻohui i nā haʻawina a hiki ke pili pū me nā hana i loko o ka hoʻomohala cognitive, craving, hoʻopaʻi i kuhikuhi ʻia, a me nā hana hana i nā kumuhana IGD [66].

Pili kekahi haʻawina hoihoi i nā kumuhana o ka IGD me nā kumuhana o ke kala ʻana mai ka IGD a me ka kaohi i loko o ka cue-induced craving e pāʻani i nā pāʻani pūnaewele [67]. Pateral dorsolateral PFC, precuneus, left gyrus parahippocampal, PCC, a me ACC ʻĀkau i hana ʻia e pane ai i nā puʻupuʻu pāʻani i ka hui ʻo IGD i hoʻohālikelike ʻia me ka hui mana. ʻO kēia mau ʻōkuhi kuhi hoho e hōʻike ana i ka lolo olakino e pili ana i ka ʻoihana o ke hoʻohui lāʻau [38, 39, 59]. Eia kekahi, hōʻike ka pūʻulu kala i ka hoʻemi ʻana o ka hoʻoneʻe ʻana ma luna o ka pors dorsolateral kūpono a waiho i ka gyrus parahippocampal ma mua o ka pūʻulu IGD. No laila, ua hōʻike aku nā mea kākau e lilo nā ʻaoʻao ʻelua i mākaʻi moho no nā mea hoʻohui i kēia manawa ma ka pāʻani pūnaewele.

Ua hoʻohana ʻia hoʻi ʻo MRI e loiloi i nā hopena therapeutic o ka lapaʻau lāʻau lapaʻau kūikawā ma IA. ʻO ka Bupropion he norepinephrine / dopamine reuptake inhibitor, ka mea i hoʻohana nui ʻia i ka mālama pono ʻana o nā maʻi me ka hōʻino kino. Ua noiʻi ʻia kahi haʻawina kūpono i ka hiki ʻana o ka bupropion, i ka noʻonoʻo ʻia o ka hana noʻonoʻo i ka pane ʻana i nā puʻupuʻu pāʻani e hoʻohana ana i ka fMRI [68]. Hōʻike ʻo IGD i ka hoʻōho kiʻekiʻe ma ka limu occipital, waiho dorsolateral PFC, a waiho i kahi gyrus parahippocampal ma mua o nā kāohi. Ma hope o nā wikiō 6 o ka mālama bupropion, he haʻahaʻa ka makemake a me ka nui o ka manawa i makemake ʻia e pāʻani ai. ʻO ka hana noʻonoʻo c c--induced in dorsolateral PFC ua hōʻemi ʻia, i hōʻike ʻia he mau pono ʻo bupropion. E like me ka mea i hōʻike mua ʻia, hōʻike ka poʻe individu ma ka IGD i ke kala ʻana i ka hoʻoneʻe ʻana ma luna o ka pors dorsolateral kūpono a waiho i ka parahippocampal gyrus [67]. No laila, ʻo ka molaging molaging i hiki ke kōkua i nā kauka lapaʻau e hoʻoholo i ka mālama kūpono loa no nā maʻi maʻi pilikino a nānā i kā lākou holomua i ka hoʻōla.

3. Loaʻa i ka ʻike ʻike ʻia ʻo Nuklei

Hōʻailona ka pale aku o Nuclear, ʻo ia hoʻi ʻo SPECT a me PET, loaʻa nā haʻawina o ke ʻano kiʻekiʻe intrinsic kiʻekiʻe, ka palena ʻole o ka hohonu hohonu, a me ka pālahalaha o nā keʻena lapaʻau e ʻike nei i nā molekule '70]. Hāʻawi ka SPECT a me PET i ka ʻikeʻike i ka hoʻoliʻi ʻana o ka ikehu ma vivo ma o ke kaomi ʻana i ka ʻai nui o ka glucose, ka poholima cerebral, a me ka make o ka oxygen. I ka noiʻi neuroscience, hiki iā ia ke aʻo ʻana i nā hana neural, a me nā kaʻina maʻi, pili ʻia i ka metabolism a me ka hana [71]. Loaʻa i ko PET nā pono keu aʻe o ka hāʻawi ʻana i ke kiʻekiʻe kiʻekiʻe o ka spatial ma mua o ka SPECT. No ka hoʻohui ʻana o ka pākīpī o ka cerebral metabolism, hiki iā PET a me SPECT ke hana hou aku i nā kikoʻī kikoʻī hou o ka neʻe ʻana o ka pae o ka neurotransmitter ma o ka hoʻohana ʻana i nā radiotracers neurotreceptor kūikawā [72].
3.1. PET Hoʻōla o nā Hoʻololi molino ʻo Brain

Ke hoʻohana nei i 18F-fluoro-deoxyglucose (18F-FDG) PET imaging, kahi noiʻi i noiʻi i nā ʻano o ka metabolism cerebral glucose i kahi hoʻomaha hoʻomaha ma waena o nā poʻe'ōpiopio me ka IGD a me ka poʻe me ka hoʻohana maʻamau [73]. Hōʻike nā hopena o ke hōʻike ʻana i hoʻonui nui ʻia ka glucose metabolism i ka waena waena o OFC, haʻalele caudate nucleus, a me ka ʻula insula a hoʻemi ʻia ka metabolism i loko o ka gyrus postcentral gyrus, nā gyrus precentral, a me nā ʻāpana bilateral occipital i hoʻohālikelike ʻia me nā mea hoʻohana maʻamau. Hōʻike nā hopena i ka IGD e pili ana me ka abnormality neurobiological i nā ʻĀina OFC, striatum, a me nā wahi sensory, kahi i hāpai ʻia ma ka kaohi o ke kolo, hoʻomaikaʻi ʻana i ka uku, a me kahi hoʻohanohano o nā ʻike mua.

3.2. Hoʻoponopono o nā Nuklearena o nā Abnormalities o Neuroreceptor

Ua hōʻike ʻia nā hōʻike hōʻike e pili ana ka lawelawe dopaminergic i ka hoʻohui i ka lāʻau [74, 75]. Ke aʻo ʻia ʻana e hoʻokele ʻia e Koepp et al. ua hoʻohana ʻia ka raclopride a inoa 11C a me nā pēpē PET e nānā i ka hoʻokuʻu dopamine endogenous i ka striatum kanaka i ka wā wikiō [76]. ʻO ka hiki ʻana o ka radioligand 11C-raclopride i nā ʻae lāʻau dopamine D2 e pili ana i nā pae o ka dopamine endogenous, hiki ke ʻike ʻia he mau loli i ka hiki ʻana o ka radioligand. Ua hōʻike aku nā mea kākau e hoʻopili ana ʻo 11C-raclopride i nā ʻoniwa dopamine i ka striatum i ka wā o ka pāʻani wikiō e hoʻohālikelike ʻia i nā pae pae o ka paʻa, ka mea i manaʻo ai e hoʻonui a hoʻopaʻa i ka dopamine i kāna mau mea pane. Eia kekahi, ua hōʻike lākou he hopena nui ma waena o ka hana o ka hana i ka wā o ka hana a hōʻemi i ka hana 11C-raclopride e hiki ai i ka striatum. Ua hōʻike ʻia nā hopena like i loko o nā poʻe me IA [77]. ʻO nā kānaka pilikino me IA i hōʻemi i ka loaʻaʻana o ka receptor dopamine D2 i ka striatum i hoʻohālikelike ʻia me nā kālai. Eia kekahi, aia i kahi hopena kino o ka loaʻa ʻana o ka dopamine receptor me ka hōʻino o IA. Kākoʻo kēia mau loiloi iā Han et al. ka mea nāna i noiʻi i ka genym polymorphism o ka ʻōnaehana dopaminergic ma kahi pūʻulu o nā mea pāʻani pāʻani hoʻoili pūnaewele Internet [78]. Ua hōʻike lākou i ka poʻe me ka nui o ka polymorphism genetic i ka hoʻopaloli genes no ka DopN D2 receptor a me ka dopamine degradation enzyme iʻoi aku ka maʻalahi ma ka pāʻani pūnaewele i hoʻohālikelike ʻia me nā mana o ka makahiki.

ʻO ka Dopamine transporter kahi protein membrane plasma e hoʻoikaika ikaika i ka unuhi i ka dopamine mai ka wahi extracellular i loko o ka presynaptic neurons [79]. Ka hoʻololi ʻia ka dopamine transporter kaomi ma ka striatum ma hope o ka hoʻokō mau ʻana i nā mana maʻi i hōʻike ʻia ma mua [80, 81]. Ke hoʻohana nei ʻo SPECT me ka radiotracer 99mTc-TRODAT-1, ua noiʻi ʻia i kā mākou hui hui striatal dopamine transporter density i loko o IA e ʻike ai i nā mana koho presynaptic [82]. Hōʻike mākou i ka hoʻohaʻahaʻa nui o ka hōʻike dopamine transporter i ka hoʻohaʻahaʻa nui loa a me ka nui, ke kaumaha, a me 99mTc-TRODAT-1 uptake ratio of corpus striatum i hoʻemi nui ʻia i ka poʻe me ka IA hoʻohālikelike me nā mana. Lawe pū ʻia kēia mau hopena e pili ana i ka pili o IA me ka disfunction o ka ʻōnaehana dopaminergic.

I kahi noiʻi hohonu hou aʻe, ua noiʻi kā mākou hui i kēlā me ka dopamine D2 receptor a me ka metabolism glucose i nā poʻe like like me ka hoʻohana ʻana i ka PET me 11C-N-methylspiperone (11C-NMSP) a me 18F-FDG, ma nā wahi ʻelua o ka hoʻomaha ʻana a me ka hana pāʻani pūnaewele. 69]. ʻO ka emi nui o ka hoʻohaʻahaʻa glucose i mālama ʻia i loko o nā hanana prefrontal, temporal, a me nā limu i nā kumuhana IGD. Ma ka hoʻomaha hoʻomaha, ka haʻahaʻa haʻahaʻa o 11C-NMSP binding i ʻike ʻia i loko o ka gyrus temporal haʻahaʻa kūpono loa i nā kumuhana IGD e hoʻohālikelike ʻia i nā mana maʻamau (Figure 2 (a)). Ma hope o ka hana pāʻani Pūnaewele, 11C-NMSP e pili ana i ka waiwai ma ka striatum ka haʻahaʻa loa i nā kumuhana IGD i hoʻohālikelike ʻia me nā mana, e hōʻike ana i ka hōʻemi o ka ʻae o dopamine D2 (Figure 2 (b)). Ka hoʻoponopono ʻia ʻana o ka mea nānā dopamine D2 e hoʻopili ʻia i nā makahiki o ka hoʻohana ʻana i ka pūnaewele (Figure 2 (d)). ʻO ka mea nui, ma nā kumuhana IGD, haʻahaʻa haʻahaʻa o dopamine D2 receptor i ka striatum ua hoʻopau ʻia me ka hoʻohaʻahaʻa ʻana i ka hana metabolism i loko o ka OFC. Hōʻike kēia mau hopena i ka dopamine D2 receptor medireg dysregulation o OFC hiki i ka mālamina o kahi hana no ka nalowale o ka kaohi a me ka hana i hoʻopaʻa ʻia ma nā kumuhana IGD.

Hōʻike 2: 11C-NMSP PET imaging o ka dopamine D2 receptor i loaʻa i nā kumuhana IGD. (a) Ma ka hoʻomaha hoʻomaha, ka haʻahaʻa haʻahaʻa o 11C-NMSP binding i loaʻa ma ka puʻuwai kino temporal kūpono i loko o nā kumuhana IGD i hoʻohālikelike ʻia i nā mana (ʻāpana ʻoniʻoni) (uncorrected,). (b) I ka mokuʻāina o ke pāʻani pāʻani, ʻo 11C-NMSP ka mea i paʻa i ka putamen i haʻahaʻa loa i ka pūʻulu IGD ma mua o ka pūʻulu o ka mana, a ma ka ʻaoʻao ʻākau (ka kala melemele (uncorrected,). (c) ʻO nā ʻākau ʻākau (,) a me nā waiho lima no ka 11C-NMSP o ka palena lima (,) i hōʻino maikaʻi me ka kiʻi ʻōpio i nā kumuhana IGD. (d) ʻO ka hema hema o OFC i ka paina cerebellum o 11C-NMSP e hoʻopili kino ana me ka hewa me ka lōʻihi o ka hoʻohana ʻana i ka pūnaewele (,) [69].

Mai kēia mau hopena, hōʻike i ka hōʻike like ʻana o IA i nā mīkini like me nā loiloi like me ka hoʻohui ʻana i ka lāʻau lapaʻau. Eia nō naʻe, aia kahi hōʻike e hōʻike ana he nui nā kūʻokoʻa i ka hana neʻōmaʻomaʻo o nā hana ʻalani like ʻole [83]. I loko o kahi hōʻikeʻike, Badiani et al. hoʻolako i nā hōʻike e pili ana i ka addiate addiction a me psychostimulant addally he whanali a me ka neurobiologically wehe, a pili kēia mau ʻokoʻa i nā mea ʻē aʻe [83]. No laila, ʻo ka hoʻomaopopo ʻana i nā hana neurobiological i lalo o ke IA he mea pono no ka hoʻomohala ʻana i ka pili lapaʻau pono a me ka hopena.

4. Nā hopenaʻike a me nā kūlana mua

Ua hōʻike ʻia nā hōʻike hōʻike ʻōiwi e pili ana i nā loli i ka ʻōnaehana o ka lolo a me ka hana e pili ana i ka IA i pili i nā wahi lolo i komo i ka uku, hoʻowalewale, a me nā hoʻomanaʻo ʻana, a me nā pūnao cognitive. Ua hoʻonui ʻia nā hana loea molecular a me ka hana ʻana i ka noiʻi IA, e hāʻawi nui ana i ko mākou ʻike i ka hana neʻōmaʻomaʻo. ʻO ka hapa nui o nā nīpepa mua i aʻo ʻia i nā kānaka IA ma lalo o ke kūlana hoʻomaha, hōʻoia i ka hanana a me ka hana pono i loko o ka OFC, dorsolateral PFC, ACC, a me PCC. Hiki i kēlā mau wahi ke kuleana nui i ka hoʻohanohano salience, pale paʻa, a me ka hoʻoholo ʻana i nā hoʻoholo. Ma kēia manawa, hoʻokahi wale nō aʻo ʻia ʻo PET me 11C-NMSP a me 18F-FDG i mālama ʻia ma lalo o ka hoʻomaha ʻana a me ka hana ʻana ma ka pāʻani pūnaewele ma ka poʻe hoʻokahi (a me IGD a ʻaʻole paha) a ʻike ua hiki i ka dopamine D2 Hoʻopuka mediated disregulation o ka OFC hiki ke hoʻomālamalama. ka hoʻokele no ka nalowale o ka hoʻokele a me ka hana pono i nā kumuhana IGD.

E lilo ana ʻo IA i pilikia koʻikoʻi ma ka honua holoʻokoʻa, he nui ka pono no ka mālama pono ʻana. Ua noi ʻia nā hoʻolālā lapaʻau a me ke ʻano lāʻau lapaʻau e mālama iā IA. Ua hōʻike ʻia he nui o nā lāʻau lapaʻau e hoʻohiki ana i ka mālama ʻana i ka IA, e like me antidepressants, antipsychotics, a me ka opioid receptor antagonist [84]. Ua hoʻokaʻawale ʻia ke ʻano hoʻomālamalama ʻana i hana ʻia e mālama i ka hōʻino o ka waiwai [85]. Mai ka ʻike ʻana o IA e ka like like me ka hana hōʻino kino, ua hōʻoia ʻia i ke ʻano cognitive-behavioral i hopena ma ka mālama ʻana iā IA [86]. ʻO ka noiʻi hou aʻe me ka hoʻohana ʻana i nā radiotracers kikoʻī e kuhi i nā ʻōnaehana neurotransmitter i hoʻopili ʻia e ka IA e hāʻawi i kahi kiʻi o ka mana o ka hana neurobiological i hoʻomoe ʻia e IA. Eia kekahi, hiki ke hoʻohana ʻia nā radiotracers e loiloi i nā hopena therapeutic o ka lāʻau lapaʻau lapaʻau kūikawā, no ka laʻana, me ka hoʻohana ʻana i 11C-carfentanil e nānā i ka loaʻa ʻana o ka mu-opioid a me ka wānana i nā hopena lapaʻau o nā antagonist reseptor opioid a me nā kōkua i nā kauka lapaʻau e hoʻoholo i ka hana kūpono loa no nā maʻi maʻi pilikino. . ^ E Ha yM.

Kū'ē o nā koho

Hōʻike nā mea kākau mea ʻaʻohe hakakā o ka makemake e pili ana i ka hoʻolaha ʻana o kēia pepa.

mau hoomaikai ana

Ua kākoʻo ʻia kēia hana e Kākoʻo mai ka National Key Basic Research Program o Kina (2013CB329506), National Science Foundation of China (NSFC) (81271601), a me ke Kuhina ʻepekema a ʻenehana ʻo Kina (2011CB504400).

E hoʻomaopopo '

    AI Leshner, "He mea pili i ka lolo, a he mea nui ia," Science, vol. 278, no. 5335, pp. 45 – 47, 1997. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    TE Robinson and KC Berridge, "Kahunahana," Review Review of Psychology, vol. 54, pp. 25 – 53, 2003. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    D. Sulzer, "Pehea e hoʻohui ai nā lāʻau lapaʻau ke hoʻopau ʻia nā presopaptop dopamine neurotransmission," Neuron, vol. 69, no. 4, pp. 628 – 649, 2011. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    NM Petry, F. Rehbein, DA Gentile, et al., "He ʻaeʻae kūwaho o ka honua no ka loiloi ʻana i ka pāʻani pili i ka pūnaewele me ka hoʻohana ʻana i kahi ala hou DSM-5," Addiction, vol. 109, no. 9, pp. 1399 – 1406, 2014. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    DJ Kuss, "He mea hoʻoili pāʻani pāʻani Pūnaewele: keʻike nei i kēia manawa," Psychology Research and Behavi Management Management, vol. 6, pp. 125 – 137, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    DE Greydanus a me MM Greydanus, "Hoʻohana pūnaewele, hoʻohana ʻole, a me ke addiction i nā wā'ōpiopio: nā pilikia i kēia manawa a me nā pilikia," International Journal of Adolescent Medicine and Health, vol. 24, no. 4, pp. 283 – 289, 2012. E nānā ma Google Scholar · ʻIke ma Scopus
    ʻO K. Yuan, W. Qin, Y. Liu, a me J. Tian, ​​"Pākuʻi pūnaewele: neuroimaging ka ʻike," Communicative and Integrative Biology, vol. 4, no. 6, pp. 637 – 639, 2011. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    KS ʻōpio, "Hoʻohui pūnaewele: ka puka ʻana o kahi maʻi hou," Cyberpsychology and Behaviour, vol. 1, no. 3, pp. 237 – 244, 1998. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO KW Beard a me EM Wolf, "Hoʻololi i nā loiloi diagnostic i manaʻo ʻia no ka pili ʻana i ka Pūnaewele," Cyberpsychology and Behaviour, vol. 4, no. 3, pp. 377 – 383, 2001. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    KS Yong, Hopu ʻia i ka ʻupena: Pehea e ʻike ai i nā ʻōuli o ka Pūkino Pūnaewele a me kahi Kaʻina Lanakila no ka Hoʻōla hou, John Wiley & Sons, New York, NY, USA, 1998.
    ʻO L. Widyanto a me M. McMurran, "ʻO nā hiʻohiʻona psychometric o ka hoʻāʻo ʻana ma ka pūnaewele," Cyberpsychology and Behaviour, vol. 7, no. 4, pp. 443 – 450, 2004. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO R. Tao, X. Huang, J. Wang, H. Zhang, Y. Zhang, a me M. Li, "Kahi ʻia nā mana ʻōlelo no ka hoʻokō pūnaewele," Addiction, vol. 105, no. 3, pp. 556 – 564, 2010. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    C.-H. Ko, J.-Y. Yen, S.-H. Chen, M.-J. Yang, H.-C. Lin, a o C.-F. Yen, "Nā huaʻōlelo hoʻāno i nā loiloi a me ka nānā ʻana a me ka hoʻomaʻamaʻa ʻana i ka pono o ka hoʻohui pūnaewele ma nā haumāna haumāna," Comprehensive Psychiatry, vol. 50, no. 4, pp. 378 – 384, 2009. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO NA Shapira, MC Lessig, TD Goldsmith et al., "Hoʻopapa pūnaewele pilikia: hoʻoliʻi hoʻonohonoho ʻana a me nā hōʻailona diagnostic," Depression and Anruptcy, vol. 17, no. 4, pp. 207 – 216, 2003. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO CH Ko, JY Yen, CC Chen, SH Chen, a me CF Yen, "Kahi ʻia nā hōʻike hoʻokolohua hoʻopili pūnaewele no ka poʻe ʻōpio," Journal of Nervous and Mental Disease, vol. 193, no. 11, pp. 728 – 733, 2005. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    G.-J. Meerkerk, RJJM van Den Eijnden, AA Vermulst, a me HFL Garretsen, "The Compulsive Internet Use Scale (CIUS): kekahi mau hiʻohiʻona psychometric," Cyberpsychology and Behaviour, vol. 12, no. 1, pp. 1 – 6, 2009. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO ML James a me SS Gambhir, "He molaging imaging primer: modities, imaging agents, a me nā noi," Physiological Review, vol. 92, no. 2, pp. 897 – 965, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO R. Weissleder a me U. Mahmood, "Imaging molecular," Radiology, vol. 219, no. 2, pp. 316 – 333, 2001. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    AM Blamire, "Ka ʻenehana o MRI - ka makahiki 10 e hiki mai ana?" ʻO ka Pelekane Pelekane o Radiology, vol. 81, no. 968, pp. 601 – 617, 2008. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    NK Logothetis, "Ke kumu o neural o ke koko-oxygen-level-magnetization resonance imaging signal," Philosophical Transaction of the Royal Society B: Biological Sciences, vol. 357, no. 1424, pp. 1003 – 1037, 2002. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    NK Logothetis lāua ʻo BA Wandell, "Ka wehewehe ʻana i ka hōʻailona BOLD," ʻikepili ʻikepili no Physiology, vol. 66, pp. 735 – 769, 2004. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO CM MacLeod a me PA MacDonald, "Hoʻopuka o interdimensional i ka hopena Stroop: wehe i ka hoʻonaʻauao cognitive a me neural anatomy o ka nānā," Trends in Cognitive Science, vol. 4, no. 10, pp. 383 – 391, 2000. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO K. Yuan, P. Cheng, T. Dong et al., "Ka hiapo mānoanoa o ka lauwili i ka wā ʻōpiopio ma ka pāʻani ʻana i ka pāʻani pūnaewele," PLoS ONE, vol. 8, no. 1, ʻ Articlelelo ID e53055, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    S.-B. Hong, J.-W. Kim, E.-J. Choi et al., "Hoʻopili a orbitofrontal cortical makapule i ka wā'ōpiopio o ka wā kamaliʻi me ka hoʻopili ʻana i ka pūnaewele," Kūlana a me Brain Functions, vol. 9, no. 1, ʻ Xlelo 11, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO BJ Everitt, DM Hutcheson, KD Ersche, Y. Pelloux, JW Dalley, a me TW Robbins, "The orbital prefrontal cortex and drug addiction in laboratory animals and human," Annals of the New York Academy of Science, vol. 1121, pp. 576 – 597, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO F. Lucantonio, ʻo TA Stalnaker, Y. Shaham, Y. Niv, a me G. Schoenbaum, "Ka hopena o ka orbitofrontal disfunction ma ka cocaine addiction," Nature Neuroscience, vol. 15, no. 3, pp. 358 – 366, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO AE Cavanna lāua ʻo MR Trimble, "ʻO ka precuneus: he loiloi ʻana i kāna anatomy hana a me nā ʻano hana," Brain, vol. 129, no. 3, pp. 564 – 583, 2006. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    S. Grant, ED London, DB Newlin et al., "Ka hoʻoweliweli ʻana i nā pōʻai kuhihewa i ka wā cue-elicited cocaine craving," Nā hana a ka National Academy of Science of the United States of America, vol. 93, no. 21, pp. 12040 – 12045, 1996. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    CD Kilts, JB Schweitzer, CK Quinn et al., "He hana neural e pili ana i ka ʻimi ʻana i ka lāʻau lapaʻau i nā hana hoʻokaʻa koko," Archives of General Psychiatry, vol. 58, no. 4, pp. 334 – 341, 2001. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO J. Ashburner lāua ʻo KJ Friston, "Morphometry i hoʻokumu ʻia i Voxia - nā ʻano," NeuroImage, vol. 11, no. 6 I, pp. 805-821, 2000. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    JL Whitwell, "morphometry a Voxel: kahi hana ʻakomi no ka nānā ʻana i nā loli kūloko i ka lolo," Journal of Neuroscience, vol. 29, no. 31, pp. 9661 – 9664, 2009. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    Y. Zhou, F.-C. Lin, Y.-S. ʻO Du et al., "Kino ʻia nā mea kūlohelohe ma ka pili ʻana i ka pūnaewele: he haʻawina morphometry a voxel," European Journal of Radiology, vol. 79, no. 1, pp. 92 – 95, 2011. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO K. Yuan, W. Qin, G. Wang et al., "Nā Microstructure abnormalities i ka wā'ōpiopio me ka maʻi ʻakeke pūnaewele," PLoS ONE, vol. 6, no. 6, ʻ Articlelelo ID e20708, 2011. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    C.-B. Weng, R.-B. Qian, X.-M. Fu et al., "Grey mea a me ke keokeo ka abnormalities i ka pili ana i ka pāʻani online," European Journal of Radiology, vol. 82, no. 8, pp. 1308 – 1312, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    EK Miller a me JD Cohen, "He kumuhana hoʻohui o ka prefrontal cortex function", Review Review of Neuroscience, vol. 24, pp. 167 – 202, 2001. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO RZ Goldstein a me ND Volkow, "ʻO ka hana o ka cortex prefrontal ma ke kaukaʻi: nā ʻike neuroimaging a me nā hopena hoʻopulapula," Nature Review Neuroscience, vol. 12, no. 11, pp. 652 – 669, 2011. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO G. Schoenbaum, MR Roesch, a me TA Stalnaker, "Orbitofrontal cortex, hoʻoholo i nā hoʻoholo a me ka lawe ʻana i ka lāʻau lapaʻau," Trend in Neurosciences, vol. 29, no. 2, pp. 116 – 124, 2006. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO AW MacDonald III, JD Cohen, VA Stenger, a me CS Carter, "E hoʻokaʻawale i ke kuleana o ka prefrontal a me ka anterior cingulate cortex i loko o ka hoʻomohala kognitive," Science, vol. 288, no. 5472, pp. 1835 – 1838, 2000. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO DC Krawczyk, "Mākaʻi o ka cortex prefrontal i ke kumu kūloko o ka hoʻoholo kanaka," Neuroscience and Biobehavioral Reviews, vol. 26, no. 6, pp. 631 – 664, 2002. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    NH Naqvi me A. Bechara, "Ka moku huna o ka addiction: ka insula," Trends in Neurosciences, vol. 32, no. 1, pp. 56 – 67, 2009. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    NH Naqvi, D. Rudrauf, H. Damasio, a me A. Bechara, "E hōʻino ana i ka insula ka hoʻomake i ka hōʻino i ka mea ulaula," Science, vol. 315, no. 5811, pp. 531 – 534, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    M. Contreras, F. Ceric, a me F. Torrealba, "Inactivation of the interoceptive insula e hoʻopakeʻe ana i ka moʻauwai ʻana i ka lāʻau lapaʻau a me ka malaise e hoʻoiho ʻia e lithium," Science, vol. 318, no. 5850, pp. 655 – 658, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    D. Le Bihan, J.-F. Mangin, C. Poupon et al., "Imposusion tensor imaging: kū manaʻo a me nā noi," Journal of Magnetic Resonance Imaging, vol. 13, no. 4, pp. 534 – 546, 2001. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO DS Tuch, ʻo TG Reese, ʻo MR Wiegell, a me VJ Wedeen, "Hoʻohālikelike MRI o ka hana maʻa neural design," Neuron, vol. 40, no. 5, pp. 885 – 895, 2003. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO G. Dong, E. DeVito, J. Huang, a me X. Du, "Ka leka hoʻoweliweli o ka diffusion i hōʻike i ka thalamus a me nā huaʻōmaʻomaʻo cortex mau kino i loko o ka poʻe pāʻani o ka pāʻani pūnaewele," Journal of Psychiatric Research, vol. 46, no. 9, pp. 1212 – 1216, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO F. Lin, Y. Zhou, Y. Du, et al., "Kūleʻa keʻokeʻo keʻokeʻo keʻokeʻo i ka wā'ōpiopio me ka hōʻuluʻulu pili i ka pūnaewele: kahi haʻawina helu spatial kahi noiʻi," PLoS ONE, vol. 7, no. 1, ʻ Articlelelo ID e30253, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    Q. Feng, X. Chen, J. Sun et al., "Voxel-level hoʻohālike o ka arterial spin-labeled perfusion magnetic resonance imaging ma ka wā'ōpiopio me ka pāʻani i ka pāʻani pūnaewele," ʻO ʻAilama a me nā Brain Functions, vol. 9, no. 1, ʻ Xlelo 33, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO ND Volkow, G.-J. Wang, JS Fowler, D. Tomasi, F. Telang, a me R. Baler, "Hoʻopili: ua hoʻoliʻiliʻi ka ʻike uku a hoʻonui ʻia ka noʻonoʻo ʻana e hoʻonui i ka pōʻaiapuni o ka lolo," BioEssays, vol. 32, ʻaʻole. 9, pp. 748–755, 2010. Nānā ma Publisher · Nānā ma Google Scholar · Nānā ma Scopus
    ʻO CP O'Brien, AR Childress, R. Ehrman, a me SJ Robbins, "Nā ʻano hoʻoliʻiliʻi i ka hōʻino ʻana i ka lāʻau: hiki iā lākou ke wehewehe i ka koi?" Ka Nūpepa o Psychopharmacology, vol. 12, ʻaʻole. 1, pp. 15-22, 1998. Nānā ma Publisher · Nānā ma Google Scholar · Nānā ma Scopus
    W.-N. Ding, J.-H. Kuʻi, Y.-W. Sun, a al al., "Hoʻololi ka hana pūnaewele paʻa hoʻololi i ka mana o ka hana ma ka ʻōpio'ōpio me ka hoʻohana ʻana i ka pāʻani pili pūnaewele," PLoS ONE, vol. 8, no. 3, ʻ Articlelelo ID e59902, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    S.-B. Hong, A. Zalesky, L. Cocchi et al., "E hoʻoneʻe i ka hana ʻona aʻo wili ma ka ʻōpio'ōpiopio me ka hoʻohui i ka pūnaewele," PLoS ONE, vol. 8, no. 2, ʻ Articlelelo ID e57831, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    HW Lee, J.-S. Choi, Y.-C. Shin, J.-Y. ʻO Lee, HY Jung, a me JS Kwon, "Hoʻopilikia i ka hoʻohuiʻana i ka pūnaewele: ka hoʻohālikelike ʻana me ka papaʻa pathological," Cyberpsychology, Behavioured, and Social Networking, vol. 15, no. 7, pp. 373 – 377, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO AR Aron, D. Shohamy, J. Clark, C. Myers, MA Gluck, a me RA Poldrack, "ʻO ka naʻau midbrain i ke ʻano o ka noʻonoʻo ʻana a me ka maopopo ʻole i ka wā e aʻo ai ʻoe," Journal of Neurophysiology, vol. 92, no. 2, pp. 1144 – 1152, 2004. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    C.-H. Ko, T.-J. Hsieh, C.-Y. Chen et al., "Hoʻololi ka lolo hana i ka wā o ka pale ʻana a me ka hoʻokaʻawale hewa ʻana i nā kumuhana me ka pāʻani pūnaewele Pūnaewele: he haʻawina hana hoʻonaninani ʻano hana," European Archives of Psychiatry and Clinical Neuroscience, 2014. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO SL Fryer, SF Tapert, SN Mattson, MP Paulus, AD Spadoni, a me EP Riley, "Ka hopena o ka waiʻona Prenatal e pili ana i ka pane ʻana i ka mua o mua-striatal i ka wā pale o ka pale aku," Alcoholism: Clinical and Experimental Research, vol. 31, no. 8, pp. 1415 – 1424, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    G. Dong, EE DeVito, X. Du, a me Z. Cui, "He pale hoʻomehana pale ʻole i loko o ka" piliona pili i ka pūnaewele ": ka hana noiʻi magnetic resonance aʻoi aku," Psychiatry Research-Neuroimaging, vol. 203, no. 2-3, pp. 153 – 158, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO MM Botvinick, JD Cohen, a me CS Carter, "Ka nānā nānā kaua a me ka aniani cingulate cortex: he whakahou," Trends in Cognitive Science, vol. 8, no. 12, pp. 539 – 546, 2004. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO CS Carter lāua ʻo V. Van Veen, "Cortex Anterior cingulate a me ka ʻike hakakā: he hōʻano hou o ka manaʻo a me ka ʻikepili," Cognitive, Affective and Behavial Neuroscience, vol. 7, no. 4, pp. 367 – 379, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO R. Leech a me DJ Sharp, "ʻO ka hana o ka pouulate cingulate cortex i loko o ka ʻōpū a me ka maʻi," Brain, vol. 137, no. 1, pp. 12 – 32, 2014. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO Y. Zang, T. Jiang, Y. Lu, Y. He, a me L. Tian, ​​"ʻO ka ʻōnaehana kamaʻāina kūloko i ka loiloi data ʻo fMRI," NeuroImage, vol. 22, no. 1, pp. 394 – 400, 2004. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO G. Dong, J. Huang, a me X. Du, "ʻO nā hoʻololi ʻana i ka home homogeneity o ka hoʻomaha ʻana i ka hana o ka lolo i ka hana ma ka pāʻani honua," ʻAilule a me Brain Functions, vol. 8, ʻ Xlelo 41, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    C.-H. Ko, G.-C. Liu, S. Hsiao et al., "Nā hana Brain pili i ke pāʻani i ka pāʻani i ke pāʻani pili ʻana i ka pāʻani pūnaewele," Journal of Psychiatric Research, vol. 43, no. 7, pp. 739 – 747, 2009. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO Y. Sun, H. Ying, RM Seetohul et al., "Brain fMRI study of crave induced by cue pictures in online game addict ('ōpiopio kāne)," Behavioural Brain Research, vol. 233, no. 2, pp. 563 – 576, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    C.-H. Ko, G.-C. Liu, J.-Y. Yen, C.-F. Yen, C.-S. Chen, a me W.-C. Lin, "ʻO ka hana o ka lolo no ka hoʻonaninani ʻana i ka pāʻani cue-induction a me ka makemake makemake i ka uahi ma waena o nā kumumanaʻo e pili ana i ka pāʻani pūnaewele a me ka hilinaʻi nikotine," Journal of Psychiatric Research, vol. 47, no. 4, pp. 486 – 493, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO DH Han, YS Kim, YS Lee, KJ Min, a me PF Renshaw, "Ka hoʻololi i ka hana cue-induced, prefrontal cortex activity me ka pāʻani i ke wikiō," Cyberpsychology, Behavioured, and Social Networking, vol. 13, no. 6, pp. 655 – 661, 2010. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ND Volkow, G.-J. Wang, JS Fowler, a me D. Tomasi, "He mea hoʻohui i loko o ka ʻōpū o ke kanaka," Hōʻike Hōʻike Kūʻai ʻo Pharmacology a Toxicology, vol. 52, pp. 321 – 336, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    C.-H. Ko, G.-C. Liu, J.-Y. Yen, C.-Y. Chen, C.-F. Yen, a me C.-S. Chen, "Hoʻokomo ʻo Brain i ka makemake no ka pāʻani pūnaewele ma lalo o ka hōʻike ʻana i nā kumuhana me nā mea pili i ka pāʻani pūnaewele a me nā kumuhana i lawe ʻia," Addiction Biology, vol. 18, no. 3, pp. 559 – 569, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO DH Han, JW Hwang, a me PF Renshaw, "ʻO ka mālama ʻana i mālama ʻia ʻo Bupropion e hōʻemi i ka makemake no nā pāʻani wikiō a me ka hana naʻau cue-i kūpono i nā mea maʻi me nā mea pāʻani o ka wikiō wikiō," Experimental and Clinical Psychopharmacology, vol. 18, no. 4, pp. 297 – 304, 2010. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    M. Tian, ​​Q. Chen, Y. Zhang, et al., "Ka hoʻopōmaʻomaʻo PET ka hōʻike ʻana i nā loli o ka lolo i ka pāʻani ʻana i ka pāʻani pūnaewele," European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 7, pp. 1388 – 1397, 2014. E nānā ma Google Scholar
    T. Jones a me EA Rabiner, "ʻO ka hoʻomohala ʻana, nā hana i hala, a me nā kuhikuhi e pili ana i ka lolo o PET," Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 7, pp. 1426 – 1454, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ME Phelps, "ʻO Positron emission tomography e hoʻolako nei i ka hana hoʻomohala o nā kaʻina hana kūlohelohe," Ka Hoʻohui ʻana o nā National Academy of Science of the United States of America, vol. 97, no. 16, pp. 9226 – 9233, 2000. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    M. Laruelle, "Hoʻopili i ka neurotransmission synaptic me nā hana hoʻokūkū vivo e hoʻopaʻa nei: i ka loiloi kūkākūkā," Ka Nūpepa o ka Cerebral Blood Flow a me Metabolism, vol. 20, no. 3, pp. 423 – 451, 2000. E nānā ma Google Scholar · ʻIke ma Scopus
    ʻO HS Park, SH Kim, SA Bang, EJ Yoon, SS Cho, a me SE Kim, "Ua hoʻololi ʻia ke kākīkī o ka cerebral glucose i loko o ka punaewele o ka punaewele: he 18F-fluorodeoxyglucose positron emission tomography study," CNS Spectrums, vol. 15, no. 3, pp. 159 – 166, 2010. E nānā ma Google Scholar · ʻIke ma Scopus
    JD Berke a me SE Hyman, "Addiction, dopamine, a me nā molekule mole mākaukau o ka hoʻomanaʻo," Neuron, vol. 25, no. 3, pp. 515 – 532, 2000. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ND Volkow, JS Fowler, G.-J. Wang, JM Swanson, a me F. Telang, "Dopamine i ka hōʻino ʻana i ka lāʻau lapaʻau a me ka hoʻohui hana: nā hopena o nā hana imaging a me nā hopena lapaʻau," Archives of Neurology, vol. 64, no. 11, pp. 1575 – 1579, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    MJ Koepp, RN Gunn, AD Lawrence et al., "He hōʻike no ka hoʻokuʻu ʻana i ka dopamine striatal i kahi pāʻani wikiō," Nature, vol. 393, no. 6682, pp. 266 – 268, 1998. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    SH Kim, S.-H. Baik, CS Park, SJ Kim, SW Choi, a me SE Kim, "Ua hōʻemi ʻia nā koina dopamine D2 striatal i loko o ka poʻe me ka hoʻohui honua," NeuroReport, vol. 22, no. 8, pp. 407 – 411, 2011. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO DH Han, YS Lee, KC Yang, EY Kim, IK Lyoo, a me PF Renshaw, "ʻO nā gen Dopamine a me ka hilinaʻi kūlike i ka wā'ōpiopio me ka pāʻani wikiō pāʻani wikiō," Journal of Addiction Medicine, vol. 1, no. 3, pp. 133 – 138, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO RA Vaughan lāua ʻo JD Foster, "Hoʻomoe o ka hoʻoponopono kaʻa transporter dopamine i nā ʻāina maʻamau a me nā maʻi," Trends in Pharmacological Science, vol. 34, no. 9, pp. 489 – 496, 2013. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO BK Gorentla a me RA Vaughan, "Nā hopena hopena o ka dopamine a me nā lāʻau lapaʻau psychoactive ma ka dopamine transporter phosphorylation a me ka hoʻoponopono," Neuropharmacology, vol. 49, no. 6, pp. 759 – 768, 2005. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO KC Schmitt lāua ʻo MEA Reith, "Ka hoʻoponopono o ka mea hoʻopuka dopamine: nā mea i pili i ka lāʻau lapaʻau ʻona psychostimulant," Annals of the New York Academy of Science, vol. 1187, pp. 316 – 340, 2010. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    H. Hou, S. Jia, S. Hu et al., "Hoemi i ka lawe ana i ka dopamine striatal na kanaka me ka maʻi ma muli o ka pūnaewele," Journal of Biomedicine and Biotechnology, vol. 2012, ʻ Articlelelo ID 854524, 5 mau ʻaoʻao, 2012. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    A. Badiani, D. Belin, D. Epstein, D. Calu, a me Y. Shaham, "Opiate versus psychostimulant addiction: ke ʻano o nā ʻokoʻa nā ʻokoʻa," Nature Review Neuroscience, vol. 12, no. 11, pp. 685 – 700, 2011. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO AM Przepiorka, A. Blachnio, B. Miziak, a me SJ Czuczwar, "Hiki ke kauka lāʻau lapaʻau i ka mālama ʻana i ka pili ma ka pūnaewele," Pharmacological Reports, vol. 66, no. 2, pp. 187 – 191, 2014. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    ʻO L. Dutra, G. Stathopoulou, SL Basden, TM Leyro, MB Powers, a me MW Otto, "He hōʻike meta-analytic o nā kikowaena psychosocial no ka hoʻohana ʻana i nā lāʻau," The American Journal of Psychiatry, vol. 165, no. 2, pp. 179 – 187, 2008. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus
    KS ʻĀnō, "ʻo ka hoʻōla ʻana e hana ai me ka pili o ka pūnaewele: nā hopena a me nā hopena," Cyberpsychology and Behaviour, vol. 10, no. 5, pp. 671 – 679, 2007. ʻIke ma Publisher · Nānā ma Google Scholar · ʻIke ma Scopus